Revenio Group Oyj published an OCT analysis from the ACUITY trial highlighting how Privosegtor helped preserve GCIPL thickness in the retina during acute episodes.
Public source
Publisher name
Public post
Thank you, Pr Timothy Lai, MD, MBBS, FRCSEd, FRCOphth, for your insightful presentation at the APVRS Retina Future Forum. The new OCT analysis from the #ACUITY trial hig…
Company
Revenio Group Oyj
Revenio is a global provider of comprehensive eye care diagnostic solutions.
- Industry
- Medical Device
- Location
- Vantaa, FI
- Company size
- 11–50 employees
About Revenio Group Oyj
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. Revenio on kansainvälisillä markkinoilla toimiva kokonaisvaltaisten silmien hoidon diagnostiikkaratkaisuiden toimittaja. Konserni tarjoaa nopeita, helppokäyttöisiä ja luotettavia työkaluja glaukooman, diabeettisen retinopatian ja silmänpohjan rappeuman diagnosointiin. Revenio-konsernin silmän diagnostiikkaratkaisuihin kuuluvat iCare-brändin alla silmänpaineen mittauslaitteet (tonometrit), silmänpohjan kuvantamislaitteet, perimetrit ja ohjelmistoratkaisut. Revenio-konsernin liikevaihto vuonna 2024 oli 103,5 miljoonaa euroa ja liiketulos 25,0 miljoonaa euroa. Revenio Group Oyj:n osake on listattu Nasdaq Helsinki Oy:ssä kaupankäyntitunnuksella REG1V.
See moreLatest activity
Latest activity from Revenio Group Oyj
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Nova Eye Medical
Nova Eye Medical published in August's issue of EuroTimes a feature discussing real-world data from the iTrack Global Data Registry (iTGDR) as presented at the Irish College of Ophthalmologists' annual conference in Galway earlier this year.
Research & Knowledge
iCare
iCare published a clinical case study on a 51-year-old woman with retinitis pigmentosa referred for a visual field test due to suspected glaucoma using the iCare COMPASS Automated Tracked Perimeter.
Research & Knowledge
Imagine Eyes
Imagine Eyes published findings from the KEYS natural history study at Kobe City Eye Hospital, which involved two years of research on EYS-associated retinitis pigmentosa using adaptive optics retinal cameras.
Research & Knowledge
Haag-Streit
Haag-Streit published the three-part series Clarity in Focus from The Ophthalmologist revealing how clinical data shows the Elara 900 is transforming the clinical observation experience through improved optical precision, detail resolution, and illumination quality.
Research & Knowledge
CILIATECH - Glaucoma Innovators